Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Artemisinin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 296Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fosun's Artemisinin Meds Boost Malaria Prevention in Africa
    Fosun's Artemisinin Meds Boost Malaria Prevention in Africa

    26 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fosun-pharmas-self-developed-artemisinin-medicines-inject-new-impetus-to-malaria-prevention-and-treatment-in-africa-302128373.html

    PR NEWSWIRE
    26 Apr 2024
    Share Share
    PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE AGAINST MILD AND MODERATE COVID-19.
    PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE AGAINST MILD AND MODERATE COVID-19.

    24 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/24/2285409/0/en/PULMOHEAL-ARTIVEDA-IS-CLINICALLY-ACTIVE-AGAINST-MILD-AND-MODERATE-COVID-19.html

    GLOBENEWSWIRE
    24 Aug 2021
    Share Share
    Manus Bio Awarded Additional Funding to Support its Artemisinin Program
    Manus Bio Awarded Additional Funding to Support its Artemisinin Program

    01 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/01/2203466/0/en/Manus-Bio-Awarded-Additional-Funding-to-Support-its-Artemisinin-Development-Program.html

    GLOBENEWSWIRE
    01 Apr 2021
    Share Share
    MGC Pharma expands ArtemiC™ phII clinical trial on COVID-19 patients
    MGC Pharma expands ArtemiC™ phII clinical trial on COVID-19 patients

    28 Sep 2020

    // Jessica Cummins PROACTIVE

    https://www.proactiveinvestors.com.au/companies/news/930059/mgc-pharmaceuticals-expands-artemic-phase-ii-clinical-trial-on-covid-19-patients-in-israel-and-india-930059.html

    Jessica Cummins PROACTIVE
    28 Sep 2020
    Share Share
    Mateon and Asili Research Alliance Enter Into Partnership for the Development
    Mateon and Asili Research Alliance Enter Into Partnership for the Development

    20 Jul 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19/

    BIOSPACE
    20 Jul 2020
    Share Share
    Mateon Therapeutics to fund observational studies of Artemisinin
    Mateon Therapeutics to fund observational studies of Artemisinin

    13 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/13/2061115/0/en/Mateon-Therapeutics-to-fund-observational-studies-of-Artemisinin-in-developing-countries.html

    GLOBENEWSWIRE
    13 Jul 2020
    Share Share